Cost-Sharing Ratio of Anti-neoplastic Drugs Impacts on the Medical Costs under Medical Insurance Catalogue: Based on the Empirical Analysis of Nantong

doi:10.7664/CHE20151206

Home>Articles>Cost-Sharing Ratio of Anti-neoplastic Drugs Impacts on the Medical Costs under Medical Insurance Catalogue: Based on the Empirical Analysis of Nantong

DOI: 10.7664/CHE20151206

Cost-Sharing Ratio of Anti-neoplastic Drugs Impacts on the Medical Costs under Medical Insurance Catalogue: Based on the Empirical Analysis of Nantong

Keywords：medical insuranceantineoplastic drug catelogueself-payment ratiomedical expenditurebrand druggeneric drugNantong

Publication Date：2015-01-01

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 22-25 )

Chinese Health Economics

PKUISTIC

ISSN：1003-0743

Year, Vol.(Issue)：2015,34(12)